Jazz Pharma Plc (JAZZ)
$164.20
1.55 (0.94%)
JAZZ Stock Quote Delayed 30 Minutes
Previous Close
-
Market Cap
9.51B
PE Ratio
22.49
EPS
7.3
Volume (Avg. Vol.)
11,840
Day's Range
164.01 - 165.50
52-Week Range
86.88 - 178.64
Dividend & Yield
N/A (N/A)
JAZZ Stock Predictions, Articles, and Jazz Pharma Plc News
3 Marijuana Stocks With High Hopes for the Future
Marijuana stocks are soaring higher on a string of Democratic electoral wins. But not every company in this troubled sector is a winner.
GWPH Stock: 12 Things to Know About the GW Pharma-Jazz Pharma Deal
GW Pharmaceuticals (GWPH) stock is soaring higher on Wednesday following news that Jazz Pharmaceuticals (JAZZ) is acquiring the company.
This Coronavirus Crisis Will Mint Millionaires
History shows that not only is there an opportunity to buy during a crisis, but that the best performers are the small caps.
5 Safe Stocks to Buy With Low Price-to-Book Ratios
P/B ratio is a convenient tool to identify low-priced stocks that have high-growth prospects. Here are five stocks with low P/B ratios.
5 Low Price-to-Book Stocks Worth Buying in July
P/B ratio is emerging as a convenient tool to identify low-priced stocks that have high-growth prospects. Compare Brokers....
10 Pharmaceuticals Stocks to Sell Now
This week, the ratings of 10 Pharmaceuticals stocks on Portfolio Grader are down. Each of these rates a "D" ("sell") or "F" overall ("strong sell").
Is 70% an Excessive Premium for Celator Pharmaceuticals Inc? (CPXX JAZZ)
Jazz Pharmaceuticals stock is hovering around breakeven after agreeing to acquire Celator (CPXX) for a 73% premium. Does the deal make sense?
The Best 7 Stocks to Buy for 2016
Was 2015 the final nail in the coffin for buy-and-hold investing? Not necessarily. Buy these 7 names and hold for 2016 before letting them go
2 Biotech Stocks to Buy After Earnings
Actavis (ACT) and Jazz Pharmaceuticals (JAZZ) reported outstanding Q3 earnings and are strong biotech stocks to buy.
Navellier Ratings
Powered by Portfolio GraderTotal Grade
B
